LIVe2024 intends to be a unique exchange platform for scientists interested in in vitro respiratory researches, stakeholders from academia, pharma, biotech, chemical, tobacco, consumer goods, medical devices industries, CROs and regulatory agencies.

The meeting focuses on predictive in vitro lung models designed for basic research, efficacy and toxicity testing. It aims at presenting the use of state-of-the-art in vitro lung models including ALI reconstructed epithelia, organoids, PCLSs, lung-on-a-chips made of cell lines, IPSCs, primary respiratory and immune cells.